Viewing Study NCT07279766


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2025-12-28 @ 6:19 AM
Study NCT ID: NCT07279766
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-11-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19
Sponsor: Tor Biering-Sørensen
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: DAN-COVID
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View